Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.73 EUR | +0.81% |
|
-1.07% | 0.00% |
Sales 2024 * | 346M 253M 237M | Sales 2025 * | 356M 261M 244M | Capitalization | 553M 405M 379M |
---|---|---|---|---|---|
Net income 2024 * | 2M 1.46M 1.37M | Net income 2025 * | 13M 9.51M 8.9M | EV / Sales 2024 * | 1.6 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.55 x |
P/E ratio 2024 * |
191
x | P/E ratio 2025 * |
53.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.52% |
Latest transcript on Knight Therapeutics Inc.
1 week | -1.07% | ||
Current month | -4.64% | ||
1 month | -7.04% | ||
3 months | +5.11% |
![Extreme 3.64](/images/extremecours_fleche.png)
![Extreme 3.64](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 55 | 13-10-31 |
Jonathan Goodman
FOU | Founder | 56 | 13-10-31 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 16-06-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Gale
BRD | Director/Board Member | 74 | 14-01-05 |
Jonathan Goodman
FOU | Founder | 56 | 13-10-31 |
Robert Lande
BRD | Director/Board Member | 61 | 12-12-31 |
Date | Price | Change |
---|---|---|
24-06-26 | 3.68 | -0.54% |
24-06-25 | 3.7 | +0.54% |
24-06-24 | 3.68 | +0.55% |
24-06-21 | 3.66 | -1.08% |
24-06-20 | 3.7 | +1.09% |
Delayed Quote Börse Stuttgart, June 26, 2024 at 02:03 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.03% | 9.11B | |
-24.00% | 4.44B | |
+13.37% | 4.24B | |
+31.17% | 4.03B | |
+7.68% | 2.14B | |
-34.04% | 1.9B | |
+7.56% | 1.94B | |
-0.50% | 1.64B | |
-47.93% | 1.63B |
- Stock Market
- Equities
- GUD Stock
- 04K Stock